日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotection.

拓扑异构酶抑制剂Topobexin靶向拓扑异构酶II ATPase结构域,选择性抑制β亚型,发挥蒽环类药物心脏保护作用

Kubeš Jan, Karabanovich Galina, Cong Anh T Q, Melnikova Iuliia, Lenčová Olga, Kollárová Petra, Bavlovič Piskáčková Hana, Keresteš Veronika, Applová Lenka, Arrouye Lise C M, Alvey Julia R, Paluncic Jasmina, Witter Taylor L, Jirkovská Anna, Kuneš Jiří, Štěrbová-Kovaříková Petra, Austin Caroline A, Štěrba Martin, Šimůnek Tomáš, Roh Jaroslav, Schellenberg Matthew J

Daunorubicin and its hydroxy metabolite in cardiomyocytes: insights into cellular kinetics, toxicity, DNA damage, and dexrazoxane-induced cardioprotection.

柔红霉素及其羟基代谢物在心肌细胞中的作用:对细胞动力学、毒性、DNA损伤和右雷佐生诱导的心脏保护作用的深入了解

Applová Lenka, Dudášová-Hatoková Paulína, Kubeš Jan, Váňová Nela, Keresteš Veronika, Reguli Adam, Jirkovská Anna, Roh Jaroslav, Štěrba Martin, Štěrbová-Kovaříková Petra, Šimůnek Tomáš

Characterization of a new model of chemotherapy-induced heart failure with reduced ejection fraction and nephrotic syndrome in Ren-2 transgenic rats.

对 Ren-2 转基因大鼠化疗诱发的心力衰竭(射血分数降低)和肾病综合征新模型进行表征

Gawrys Olga, Jíchová Šárka, Miklovič Matúš, Husková Zuzana, Kikerlová Soňa, Sadowski Janusz, Kollárová Petra, Lenčová-Popelova Olga, Hošková Lenka, Imig John D, Mazurova Yvona, Kolář František, Melenovský Vojtěch, Štěrba Martin, Červenka Luděk

Long-term (>10-year) clinical follow-up after young embolic stroke/TIA of undetermined source

对年轻患者不明原因栓塞性卒中/短暂性脑缺血发作进行长期(>10年)临床随访

Nassif, M; Annink, M E; Yang, H; Rettig, Tcd; Roos, Ybwem; van den Brink, Rba; Tijssen, Jgp; Mulder, Bjm; de Winter, R J; Bouma, B J